• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Effects of Patient Characteristics on the Management of Subclinical Hypothyroidism: A Survey of Faculty and Trainees.患者特征对亚临床甲状腺功能减退症管理的影响:对教师和学员的调查。
Endocr Pract. 2023 Oct;29(10):787-793. doi: 10.1016/j.eprac.2023.07.031. Epub 2023 Aug 6.
2
Patient-Reported Satisfaction with Thyroid Hormone Replacement Therapy for Subclinical Hypothyroidism in Older Adults: A Pooled Analysis of Individual Participant Data from Two Randomized Controlled Trials.老年亚临床甲状腺功能减退症患者对甲状腺激素替代治疗的满意度:两项随机对照试验的个体参与者数据汇总分析。
Thyroid. 2024 Jun;34(6):702-712. doi: 10.1089/thy.2023.0624. Epub 2024 May 3.
3
Prevalence of thyroid autoimmunity and effect of levothyroxine treatment in a cohort of 1064 patients with recurrent pregnancy loss.1064例复发性流产患者队列中甲状腺自身免疫的患病率及左甲状腺素治疗的效果
Reprod Biomed Online. 2020 Apr;40(4):582-592. doi: 10.1016/j.rbmo.2019.11.014. Epub 2019 Nov 30.
4
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss.亚临床甲状腺功能减退症对反复早期妊娠丢失妇女的影响。
Fertil Steril. 2013 Nov;100(5):1326-31. doi: 10.1016/j.fertnstert.2013.07.1975. Epub 2013 Aug 15.
5
The diagnosis and management of subclinical hypothyroidism is assay-dependent- Implications for clinical practice.亚临床甲状腺功能减退症的诊断和管理依赖于检测方法——对临床实践的影响。
Clin Endocrinol (Oxf). 2021 Jun;94(6):1012-1016. doi: 10.1111/cen.14423. Epub 2021 Feb 4.
6
L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized Trial.左甲状腺素治疗伴有亚临床甲状腺功能减退症和甲状腺功能减退症状的老年患者:一项随机试验的二次分析。
Ann Intern Med. 2020 Jun 2;172(11):709-716. doi: 10.7326/M19-3193. Epub 2020 May 5.
7
Determinants for Thyroid Hormone Replacement Therapy in Subclinical Hypothyroidism: A Multicenter Electronic Health Records-Based Study.亚临床甲状腺功能减退症患者甲状腺激素替代治疗的决定因素:一项基于多中心电子健康记录的研究。
Thyroid. 2023 Sep;33(9):1045-1054. doi: 10.1089/thy.2023.0062. Epub 2023 Jun 26.
8
Thyroid hormone therapy for subclinical hypothyroidism.甲状腺激素治疗亚临床甲状腺功能减退症。
Endocrine. 2019 Oct;66(1):27-34. doi: 10.1007/s12020-019-02039-z. Epub 2019 Oct 15.
9
How selective are the new guidelines for treatment of subclinical hypothyroidism for patients with thyrotropin levels at or below 10 mIU/L?新的亚临床甲状腺功能减退症治疗指南对于促甲状腺激素水平在 10mIU/L 或以下的患者的治疗选择有多严格?
Thyroid. 2013 May;23(5):562-5. doi: 10.1089/thy.2012.0502.
10
Transient high thyroid stimulating hormone and hypothyroidism incidence during follow up of subclinical hypothyroidism.亚临床甲状腺功能减退症随访中一过性高促甲状腺激素血症和甲状腺功能减退症的发生率。
Endocr Regul. 2021 Dec 7;55(4):204-214. doi: 10.2478/enr-2021-0022.

本文引用的文献

1
Neuropsychiatric Manifestations of Thyroid Diseases.甲状腺疾病的神经精神表现
Cureus. 2023 Jan 20;15(1):e33987. doi: 10.7759/cureus.33987. eCollection 2023 Jan.
2
Subclinical hypothyroidism, outcomes and management guidelines: a narrative review and update of recent literature.亚临床甲状腺功能减退症、结局与管理指南:近期文献的叙述性综述及更新
Curr Med Res Opin. 2023 Mar;39(3):351-365. doi: 10.1080/03007995.2023.2165811. Epub 2023 Jan 18.
3
Levothyroxine Use in the United States, 2008-2018.左甲状腺素在美国的使用情况,2008-2018 年。
JAMA Intern Med. 2021 Oct 1;181(10):1402-1405. doi: 10.1001/jamainternmed.2021.2686.
4
Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study.甲状腺替代治疗、促甲状腺激素浓度与甲状腺功能减退症患者的长期健康结局:纵向研究。
BMJ. 2019 Sep 3;366:l4892. doi: 10.1136/bmj.l4892.
5
Patient Requests for Tests and Treatments Impact Physician Management of Hypothyroidism.患者对检查和治疗的需求影响甲状腺功能减退症的医生管理。
Thyroid. 2019 Nov;29(11):1536-1544. doi: 10.1089/thy.2019.0383. Epub 2019 Oct 10.
6
Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk.甲状腺功能减退症治疗过度和不足的持续时间与心血管风险增加有关。
Eur J Endocrinol. 2019 Jun 1;180(6):407-416. doi: 10.1530/EJE-19-0006.
7
Prescribing Therapy for Hypothyroidism: Influence of Physician Characteristics.甲状腺功能减退症的处方治疗:医生特征的影响。
Thyroid. 2019 Jan;29(1):44-52. doi: 10.1089/thy.2018.0369. Epub 2018 Dec 17.
8
Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.老年亚临床甲状腺功能减退症患者的甲状腺激素治疗
N Engl J Med. 2017 Oct 5;377(14):e20. doi: 10.1056/NEJMc1709989.
9
Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment.亚临床甲状腺功能减退孕妇的甲状腺激素治疗:美国全国评估。
BMJ. 2017 Jan 25;356:i6865. doi: 10.1136/bmj.i6865.
10
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.美国甲状腺协会2017年妊娠期及产后甲状腺疾病诊断和管理指南。
Thyroid. 2017 Mar;27(3):315-389. doi: 10.1089/thy.2016.0457.

患者特征对亚临床甲状腺功能减退症管理的影响:对教师和学员的调查。

The Effects of Patient Characteristics on the Management of Subclinical Hypothyroidism: A Survey of Faculty and Trainees.

机构信息

Section of General Internal Medicine, University of Chicago, Chicago, Illinois.

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

出版信息

Endocr Pract. 2023 Oct;29(10):787-793. doi: 10.1016/j.eprac.2023.07.031. Epub 2023 Aug 6.

DOI:10.1016/j.eprac.2023.07.031
PMID:37549880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10592164/
Abstract

OBJECTIVE

There is no universal approach to the management of subclinical hypothyroidism (SCH). This study was designed to determine the impact of patient characteristics on management decisions in SCH amongst physician faculty members and trainees.

METHODS

An online survey was distributed to faculty members and medical trainees (ie, interns, residents, and fellows) at multiple academic medical centers. The survey included 9 clinical scenarios describing women with SCH with 5 management options sequenced from most "conservative" (no further treatment or monitoring) to most "aggressive" (treatment with levothyroxine).

RESULTS

Of the 194 survey respondents, 95 (49.0%) were faculty members and 99 (51.0%) were trainees. Faculty members were more likely to report being "confident" or "very confident" in making the diagnosis of SCH compared to trainees (95.8% vs 46.5%, P < .001). Faculty members were also more likely to consider patient preference for treatment (60.0% vs 32.3%, P < .001). Among all respondents, the clinical factors that resulted in the highest predicted probability of treatment were hypothyroid symptoms (predicted probability [PP] 68.8%, 95% CI [65.7%-71.9%]), thyroid stimulating hormone >10 mIU/L in a 31-year-old (PP 63.9%, 95% CI [60.3%-67.3%]), and the desire for fertility (PP 52.2%, 95% CI [48.6%-56.0%]). In general, faculty members favored more aggressive treatment across all clinical scenarios.

CONCLUSION

The presence of symptoms, thyroid stimulating hormone >10 mIU/L, and desire for fertility were most predictive of the decision to treat in SCH. In several clinical scenarios, both trainee and faculty decision-making demonstrated discordance with general SCH management principles.

摘要

目的

亚临床甲状腺功能减退症(SCH)的管理方法尚无定论。本研究旨在确定患者特征对医师教师和学员在 SCH 管理决策中的影响。

方法

我们向多家学术医疗中心的教师和医学学员(即实习医师、住院医师和研究员)分发了在线调查。该调查包括 9 个描述患有 SCH 的女性的临床情况,每个情况有 5 种管理选项,从最“保守”(无需进一步治疗或监测)到最“积极”(用左甲状腺素治疗)。

结果

在 194 名调查参与者中,95 名(49.0%)为教师,99 名(51.0%)为学员。与学员相比,教师更有可能报告“有信心”或“非常有信心”做出 SCH 诊断(95.8% 对 46.5%,P<0.001)。教师也更有可能考虑患者对治疗的偏好(60.0% 对 32.3%,P<0.001)。在所有参与者中,导致治疗预测概率最高的临床因素是甲状腺功能减退症状(预测概率[PP]68.8%,95%CI[65.7%-71.9%])、31 岁时促甲状腺激素(TSH)>10 mIU/L(PP 63.9%,95%CI[60.3%-67.3%])和生育愿望(PP 52.2%,95%CI[48.6%-56.0%])。总的来说,教师在所有临床情况下都倾向于更积极的治疗。

结论

存在症状、TSH>10 mIU/L 和生育愿望是 SCH 治疗决策的最主要预测因素。在一些临床情况下,学员和教师的决策都与 SCH 的一般管理原则不一致。